Immuneering (IMRX) Payables (2020 - 2026)
Immuneering's Payables was $2.76 million in Q3 2026, up 72.4% from $1.6 million a year earlier but down 18.3% from the prior quarter.
Powered by 
Analysis
Immuneering (IMRX) Payables (2020 - 2026) Analysis & Trends
At the end of FY2025, Payables at Immuneering came in at $1.54 million, down 21.2% from FY2024.
- Payables has now declined for three consecutive years, though with a five-year compound annual growth rate of 0.8% (FY2020 to FY2025).
- In earlier years, Payables was $1.96 million in FY2024 (-7.3%), $2.11 million in FY2023 (-33.1%), $3.15 million in FY2022 (+126.2%) and $1.39 million in FY2021 (-5.8%).
- Quarterly Payables has moved between $1.24 million (Q2 2022) and $3.38 million (Q2 2026) over five years.
- Compared with a year earlier, Payables has increased for three straight quarters, with growth averaging 3.4% over the last eight quarters.
- The best year-over-year quarter for Payables over five years was Q4 2022 (growth of 126.2%); the worst was Q1 2025 (a decline of 42.3%).
- Per Business Quant data, IMRX's Payables in the three quarters before Q3 2026 was $3.38 million (Q2 2026), $1.45 million (Q1 2026) and $1.54 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Immuneering | 246.36 Mn | -378.47 Mn | - | 2.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.76 Mn |
| Jun 30, 2026 | 3.38 Mn |
| Mar 31, 2026 | 1.45 Mn |
| Dec 31, 2025 | 1.54 Mn |
| Sep 30, 2025 | 1.60 Mn |
| Jun 30, 2025 | 2.40 Mn |
| Mar 31, 2025 | 1.31 Mn |
| Dec 31, 2024 | 1.96 Mn |
| Sep 30, 2024 | 1.94 Mn |
| Jun 30, 2024 | 2.62 Mn |
| Mar 31, 2024 | 2.27 Mn |
| Dec 31, 2023 | 2.11 Mn |
| Sep 30, 2023 | 1.94 Mn |
| Jun 30, 2023 | 2.69 Mn |
| Mar 31, 2023 | 2.72 Mn |
| Dec 31, 2022 | 3.15 Mn |
| Sep 30, 2022 | 2.34 Mn |
| Jun 30, 2022 | 1.24 Mn |
| Mar 31, 2022 | 1.64 Mn |
| Dec 31, 2021 | 1.39 Mn |
API Access
Immuneering Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=IMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "IMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=IMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();